BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10952243)

  • 1. P53 but not p16INK4a induces growth arrest in retinoblastoma-deficient hepatocellular carcinoma cells.
    Morel AP; Unsal K; Cagatay T; Ponchel F; Carr B; Ozturk M
    J Hepatol; 2000 Aug; 33(2):254-65. PubMed ID: 10952243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
    Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S
    BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aza-2'-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines.
    Suh SI; Pyun HY; Cho JW; Baek WK; Park JB; Kwon T; Park JW; Suh MH; Carson DA
    Cancer Lett; 2000 Nov; 160(1):81-8. PubMed ID: 11098088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.
    Costanzi-Strauss E; Strauss BE; Naviaux RK; Haas M
    Exp Cell Res; 1998 Jan; 238(1):51-62. PubMed ID: 9457056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators.
    Suzuki-Takahashi I; Higashi H; Yoshida E; Nishimura S; Kitagawa M
    Biochem Biophys Res Commun; 1997 May; 234(2):386-92. PubMed ID: 9177281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for cell cycle arrest by p16INK4a.
    Bruce JL; Hurford RK; Classon M; Koh J; Dyson N
    Mol Cell; 2000 Sep; 6(3):737-42. PubMed ID: 11030353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.
    Kim WH; Kang KH; Kim MY; Choi KH
    Biochem Cell Biol; 2000; 78(2):127-35. PubMed ID: 10874474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells.
    Friedman SL; Shaulian E; Littlewood T; Resnitzky D; Oren M
    Oncogene; 1997 Jul; 15(1):63-70. PubMed ID: 9233778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway.
    Lee TK; Man K; Ling MT; Wang XH; Wong YC; Lo CM; Poon RT; Ng IO; Fan ST
    Carcinogenesis; 2003 Nov; 24(11):1729-36. PubMed ID: 12949053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
    Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
    Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent alterations in the expression of tumor suppressor genes p16INK4A and pRb in esophageal squamous cell carcinoma in the Indian population.
    Ralhan R; Mathew R; Arora S; Bahl R; Shukla NK; Mathur M
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):655-60. PubMed ID: 11079730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
    Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J; Kratzke RA; Niehans GA; Lincoln CE
    Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.